Three executives from an AI ploy to deny health care to seniors are buying a troubled mega-practice from the bankrupt Steward Health. What could go wrong?
Medicare
Fantasyland General
Hospital pricing is impenetrable to consumers and regulators alike. The result: increased costs and profits, and wasteful reliance on armies of middlemen.
Medicare Advantage’s $64 Billion Supplemental Benefits Slush Fund
Medicare spends huge sums financing the dental, vision, and other benefits offered by Medicare Advantage plans. A new government report sounds the alert about their potential misuse.
The Real Entitlement Crisis: Good Reporting Is in Short Supply
The preferred journals of the power elite peddle the myth of pending Social Security catastrophe, which is catastrophically wrong.
New Bill Seeks to End Drug Shortages
The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers.
The VA Bows to the Dialysis Duopoly
Despite contracting rules in place to give veterans safe and affordable access to dialysis, DaVita and Fresenius are picking up most of the patients.
Where Does Medicare Go From Here: Profit-Driven Chaos or Patient-Centered Community?
After covering the Medicare privatization crisis for over two years, an investigative reporter takes a step back and examines what’s at stake.
Our Uniquely American Drug Shortages
More drugs are in short supply than ever before. We’ve known the reason why for a long time: monopolistic middlemen.
Will Voters Hear About Donald Trump’s Deranged Health Care Agenda?
A second Trump term means tens of millions of people losing insurance and chaos in the hospitals.
Drug Companies Are Fighting Biden’s Efforts to Lower Their Prices
Today on TAP: We should visibly fight back (good for Americans’ health and wallets, and good for Democrats’ prospects).
